Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.

Discontinuation of oral anticoagulants may expose non-valvular atrial fibrillation (NVAF) patients to an increased risk of stroke. This study describes the real-world discontinuation rates and compared the risk of drug discontinuation among NVAF patients initiating apixaban, warfarin, dabigatran, or...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Gregory Y H Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak
Format:	Artigo
Sprog:	Inglês
Udgivet:	Public Library of Science (PLoS) 2018-01-01
Serier:	PLoS ONE
Online adgang:	https://doi.org/10.1371/journal.pone.0195950
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!